EUVIMEDEUVIMED entdecken
Crossref

Clinical Impact of Drug-Coated Balloon–Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease

Eun-Seok Shin, Eun Jung Jun, Sunwon Kim, Bitna Kim, Tae-Hyun Kim, Chang-Bae Sohn, Ae-Young Her, Yongwhi Park, Jung Rae Cho, Young-Hoon Jeong, Byung Joo Choi

JACC: Cardiovascular Interventions · 2023-02 · 16 (3) · 292-299

DOI: 10.1016/j.jcin.2022.10.049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2023-02. Verfasst von Eun-Seok Shin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea. Electronic address: sesim1989@gmail…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Drug-Eluting Stents, Percutaneous Coronary Intervention, Coronary Restenosis. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Data on drug-coated balloon (DCB) treatment in the context of multivessel coronary artery disease (CAD) are limited. OBJECTIVES: The purpose of this study was to investigate the impact of DCB-based treatment on percutaneous coronary intervention for multivessel CAD. METHODS: A total of 254 patients with multivessel disease successfully treated with DCBs or in combination with drug-eluting stents (DES) were retrospectively enrolled (DCB-based group) and compared with 254 propensity-matched patients treated with second-generation DES from the PTRG-DES (Platelet Function and Genotype-Related Long-Term Prognosis in Drug-Eluting Stent-Treated Patients With Coronary Artery Disease) registry (n = 13,160) (DES-only group). Major adverse cardiovascular events (MACE) comprised cardiac death, myocardial infarction, stroke, stent thrombosis, target vessel revascularization, and major bleeding at 2 years. RESULTS: Baseline clinical characteristics were comparable between the groups. In the DCB-based group, 34.3% of patients were treated with DCBs only and 65.7% were treated with the DES hybrid approach. The number of stents and total stent length were significantly reduced by 65.4% and 63.7%, respectively, in the DCB-based group compared with the DES-only group. Moreover, the DCB-based group had a lower rate of MACE than the DES-only group (3.9% and 11.0%; P = 0.002) at 2-year follow-up. The DES-only group had a higher risk for cardiac death and major bleeding. CONCLUSIONS: The DCB-based treatment approach showed a significantly reduced stent burden for multivessel percutaneous coronary intervention and led to a lower rate of MACE than the DES-only treatment. This study shows that DCB-based treatment approach safely reduces stent burden in multivessel CAD, and improved long-term outcomes may be expected by reducing stent-related events. (Impact of Drug-Coated Balloon Treatment in De Novo Coronary Lesion; NCT04619277).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseDrug-Eluting StentsPercutaneous Coronary InterventionCoronary RestenosisHumansRetrospective StudiesTreatment OutcomeCoated Materials, BiocompatibleCoronary Angiography

Stichwörter der Autor:innen

coronary artery diseasedrug-coated balloondrug-eluting stent(s)multivesselpaclitaxel-coated balloonpercutaneous coronary intervention

Substanzen

Coated Materials, Biocompatible

Autor:innen und Institutionen

  • Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea. Electronic address: sesim1989@gmail.com.
  • Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
  • Department of Cardiology, Korea University Ansan Hospital, Ansan-si, South Korea.
  • Department of Cardiology, Ulsan Medical Center, Ulsan, South Korea.
  • Division of Cardiology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, South Korea.
  • Department of Internal Medicine, Gyeongsang National University School of Medicine and Cardiovascular Center, Jinju, South Korea.

Zitieren

APA

Shin, E. S., Jun, E. J., Kim, S., Kim, B., Kim, T. H., Sohn, C. B., Her, A. Y., Park, Y., Cho, J. R., Jeong, Y. H., & Choi, B. J. (2023). Clinical Impact of Drug-Coated Balloon–Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease. JACC: Cardiovascular Interventions, 16(3), 292-299. https://doi.org/10.1016/j.jcin.2022.10.049

Vancouver

Shin ES, Jun EJ, Kim S, Kim B, Kim TH, Sohn CB, et al. Clinical Impact of Drug-Coated Balloon–Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease. JACC: Cardiovascular Interventions. 2023;16(3):292-299. doi:10.1016/j.jcin.2022.10.049

BibTeX
@article{Shin2023,
  author = {Shin, Eun-Seok and Jun, Eun Jung and Kim, Sunwon and Kim, Bitna and Kim, Tae-Hyun and Sohn, Chang-Bae and Her, Ae-Young and Park, Yongwhi and Cho, Jung Rae and Jeong, Young-Hoon and Choi, Byung Joo},
  title = {Clinical Impact of Drug-Coated Balloon–Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease},
  journal = {JACC: Cardiovascular Interventions},
  year = {2023},
  volume = {16},
  number = {3},
  pages = {292--299},
  doi = {10.1016/j.jcin.2022.10.049}
}
Kostenlos starten →